Meteora Capital’s Viveon Health Acquisition Corp. VHAQ Stock Holding History

Meteora Capital’s Portfolio VHAQ Stock Details VHAQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-816,459	Closed	-$9.21M	–	360
2023 Q4	$9.21M	Sell	816,459 -721	-0.1%	-$8.17K	1.56%	13
2023 Q3	$9.14M	Sell	817,180 -11,516	-1%	-$129K	1.56%	10
2023 Q2	$9.12M	Sell	828,696 -39,111	-5%	-$432K	1.68%	11
2023 Q1	$9.46M	Sell	867,807 -25,012	-3%	-$267K	1.12%	17
2022 Q4	$9.51M	Buy	892,819 +679,311	+318%	+$7.08M	2.06%	11
2022 Q3	$2.21M	Buy	213,508 +129,820	+155%	+$1.34M	0.56%	52
2022 Q2	$858K	Buy	+83,688	New	+$854K	0.16%	122

Other funds holding VHAQ

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Meteora Capital's VHAQ Position: Q1 2024 in Review

Meteora Capital sold out of Viveon Health Acquisition Corp. (VHAQ) in Q1 2024, closing a stake of 816,459 shares — an estimated $9.21M sold.

Meteora Capital first reported a position in VHAQ in Q2 2022 and held it in 7 quarters. The position peaked at $9.51M in Q4 2022. 3 funds tracked by Wall St. Rank hold VHAQ as of Q1 2024.

Meteora Capital reported no remaining Viveon Health Acquisition Corp. position as of Q1 2024 after selling out during the quarter.
Meteora Capital sold 816,459 Viveon Health Acquisition Corp. shares in Q1 2024, an estimated $9.21M.
Meteora Capital first reported a position in Viveon Health Acquisition Corp. in Q2 2022 and held it in 7 quarters.
Meteora Capital's Viveon Health Acquisition Corp. position peaked at $9.51M in Q4 2022.
3 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. as of Q1 2024.

Based on Meteora Capital's 13F filing for Q1 2024, filed 14 May 2024.